Sensus Healthcare Inc (SRTS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $38.27M
Last updated: Nov 17, 2026 at 11:05 AM ET
Sensus Healthcare Inc (SRTS) Stock Forecast
Analysts expect Sensus Healthcare (SRTS) to earn -$0.76 per share in the fiscal year ending Dec 31, 2026, on revenue of $19.13M. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.17.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 3 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 47.4%.
- Fiscal year ending Dec 31, 2026
- -$0.76
- EPS consensus, revenue $19.13M
- Fiscal year ending Dec 31, 2027
- -$0.17
- EPS consensus, revenue $28.19M
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.76 | -$0.82 to -$0.66 | 3 | $19.13M | $16.60M to $22.00M | 4 |
| Dec 31, 2027 | -$0.17 | -$0.31 to -$0.06 | 3 | $28.19M | $24.76M to $31.30M | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.02 | -$0.04 to $0.01 | 6 | $6.82M | $4.51M to $8.19M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.29.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.76 | -$0.33 | -$0.33 | -$0.29 | -$0.29 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.17 | -$0.09 | -$0.09 | -$0.02 | -$0.02 | N/A |
Frequently Asked Questions About SRTS
What is the SRTS stock forecast?
Consensus analyst estimates put Sensus Healthcare's EPS at -$0.76 for the fiscal year ending Dec 31, 2026, on revenue of $19.13M. The consensus rating from 4 analysts is Buy.
How do analysts rate SRTS stock?
Of 4 analysts covering Sensus Healthcare, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SRTS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.76, with estimates from -$0.82 to -$0.66 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.17, with estimates from -$0.31 to -$0.06 from 3 analysts.
What revenue do analysts expect from Sensus Healthcare next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $19.13M, with estimates from $16.60M to $22.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $28.19M, with estimates from $24.76M to $31.30M.
How many analysts cover SRTS?
4 analysts rate Sensus Healthcare stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SRTS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors